Literature DB >> 2574367

Association between serum albumin and mortality from cardiovascular disease, cancer, and other causes.

A Phillips1, A G Shaper, P H Whincup.   

Abstract

In a prospective study of 7735 middle-aged British men (British Regional Heart Study) 660 died during an average follow-up period of 9.2 years. There was a marked increase in mortality rate with decreasing serum albumin concentrations that persisted even after adjustment for age, social class, town of residence, cigarette smoking, serum total cholesterol, systolic blood pressure, serum total calcium, and forced expiratory volume in 1 s. When serum albumin concentration was less than 40 g/l, the mortality rate was 23/1000 per year compared with 4/1000 per year for a concentration equal to or above 48 g/l. A similar pattern was observed for cardiovascular, cancer, and other deaths. The associations persisted for cardiovascular disease and cancer even when deaths within the first five years of follow-up were excluded. These results must be interpreted with caution since there was no prior hypothesis concerning serum albumin. However, the strength of the association between serum albumin and mortality seems to be comparable with that for cigarette smoking.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2574367     DOI: 10.1016/s0140-6736(89)92042-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  75 in total

1.  One-year serum albumin is an independent predictor of outcomes in kidney transplant recipients.

Authors:  Rebecca Dahlberg; Brenda Muth; Milagros Samaniego; R Michael Hofmann; John Pirsch; Arjang Djamali
Journal:  J Ren Nutr       Date:  2010-05-26       Impact factor: 3.655

2.  An evaluation of serum albumin, root caries, and other covariates in Gullah African Americans with type-2 diabetes.

Authors:  Nicole M Marlow; Elizabeth H Slate; Dipankar Bandyopadhyay; Jyotika K Fernandes; Carlos F Salinas
Journal:  Community Dent Oral Epidemiol       Date:  2010-11-10       Impact factor: 3.383

3.  Albumin is a better predictor of outcomes than body mass index following coronary artery bypass grafting.

Authors:  Castigliano M Bhamidipati; Damien J LaPar; Gaurav S Mehta; John A Kern; Gilbert R Upchurch; Irving L Kron; Gorav Ailawadi
Journal:  Surgery       Date:  2011-10       Impact factor: 3.982

4.  Site-specific conjugation of an antibody on a gold nanoparticle surface for one-step diagnosis of prostate specific antigen with dynamic light scattering.

Authors:  Nur Mustafaoglu; Tanyel Kiziltepe; Basar Bilgicer
Journal:  Nanoscale       Date:  2017-06-29       Impact factor: 7.790

5.  Getting it right: optimizing the patient and technique for the procedure.

Authors:  Alfred H Stammers
Journal:  J Extra Corpor Technol       Date:  2009-12

6.  Using computer-based medical records to predict mortality risk for inner-city patients with reactive airways disease.

Authors:  W M Tierney; M D Murray; D L Gaskins; X H Zhou
Journal:  J Am Med Inform Assoc       Date:  1997 Jul-Aug       Impact factor: 4.497

7.  Low serum total cholesterol concentrations and mortality in middle aged British men.

Authors:  G Wannamethee; A G Shaper; P H Whincup; M Walker
Journal:  BMJ       Date:  1995-08-12

8.  Hyponatremia in the outpatient setting: clinical characteristics, risk factors, and outcome.

Authors:  Vildan Tasdemir; Ali Kemal Oguz; Irmak Sayın; Ihsan Ergun
Journal:  Int Urol Nephrol       Date:  2015-10-22       Impact factor: 2.370

9.  Serum albumin level and risk for mortality and hospitalization in adolescents on hemodialysis.

Authors:  Sandra Amaral; Wenke Hwang; Barbara Fivush; Alicia Neu; Diane Frankenfield; Susan Furth
Journal:  Clin J Am Soc Nephrol       Date:  2008-02-20       Impact factor: 8.237

10.  Incidence and prognosis of non-typhoid Salmonella bacteraemia in Denmark: a 10-year county-based follow-up study.

Authors:  K O Gradel; H C Schønheyder; L Pedersen; R W Thomsen; M Nørgaard; H Nielsen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-03       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.